Tag: EACTS 2025

EACTS 2025 hears new data on aortic arch remodelling device

Data from the AMDS PERSEVERE and PROTECT trials—both assessing the use of the Ascyrus medical dissection stent (AMDS, Artivion)—were presented in late-breaking science presentations...